Early vascular aging in patients with metabolic syndrome: features of the course and diagnosis

Purpose: identifying the causes of early vascular aging (EVA) in patients with metabolic syndrome (MetS), assessing the relationship between vascular age and various metabolic disorders, the severity of metabolic syndrome , tissue and circulating risk markers, the severity of non-infectious inflammation, and derive a new score for calculation vascular age and predicting early vascular aging in patients with metabolic syndrome.

Materials and methods: а total of 750 patients aged 35 to 80 years with metabolic syndrome were examined. Early vascular aging syndrome was detected in 484 patients with metabolic syndrome and carotid-femoral pulse wave velocity (cfPWV) values exceeding expected for average age values by 2 or more SD.

Results: Multiple logistic regression shown, that presence of type 2 diabetes and IR were associated with greater risk of early vascular aging, the risk of having early vascular aging increased by 76% with an increase in HOMA-IR by 1 unit, by 17% with an increase in carotid-femoral pulse wave velocity by 1 mg/l, by 4% with an increase in DBP by 1 mm Hg, and by 1% with each 1 pmol / L increase in the level of UA. For vascular age, calculated from carotid-femoral pulse wave velocity, SCORE scale, QRISK-3 scale and Framingham scale, respectively. Diabetes mellitus and clinical markers of IR (yes/no), HOMA-IR and UA level were used to develop a new VAmets score for EVA prediction providing a total accuracy of 0.830 (95% CI 0,799 to 0,860).

Conclusion: parallel efforts for effective integration simple clinical score into clinical practice have been offered. Our score (VAmets) may accurately identify patients with metabolic syndrome and early vascular aging on the basis of widely available clinical variables and classic cardiovascular risk factors can prioritize using of vascular age in routine care.

1. Шляхто E.В., Звартау Н.Э., Виллевальде C.В., Яковлев A.Н., Соловьева А.Е., Алиева А.С., и др. Cистема управления сердечно-сосудистыми рисками: предпосылки к созданию, принципы организации, таргетные группы. Российский кардиологический журнал. 2019;(11):69-82. DOi: 10.15829/1560-4071-2019-11-69-82

2. Pucci G, Alcidi R, Tap L, Battista F, Mattace-Raso F, Schillaci G. Sex- and gender-related prevalence, cardiovascular risk and therapeutic approach in metabolic syndrome: A review of the literature. Pharmacol Res. 2017;120:34-42. DOI: 10.1016/j.phrs.2017.03.008

3. Nilsson PM. Early vascular aging (EVA): consequences and prevention. Vasc Health Risk Manag. 2008;4(3):547-52. DOI: 10.2147/vhrm.s1094

4. Laurent S, Boutouyrie P, Cunha PG, Lacolley P, Nilsson PM. Concept of Extremes in Vascular Aging. Hypertension. 2019;74(2):218-228. DOI: 10.1161/HYPERTENSIO-NAHA.119.12655

5. Ротарь О.П., Толкунова К.М. Сосудистое старение в концепциях EVA и SUPERNOVA: непрерывный поиск повреждающих и протективных факторов. Артериальная гипертензия. 2020;26(2):133-145. DOI: 10.18705/1607-419X-2020-26-2-133-145

6. Nilsson PM. Early Vascular Aging in Hypertension. Front Cardiovasc Med. 2020;7:6. DOI: 10.3389/fcvm.2020.00006

7. Bain SC, Gill GV, Dyer PH, Jones AF, Murphy M, Jones KE, et al. Characteristics of Type 1 diabetes of over 50 years duration (the Golden Years Cohort). DiabetMed. 2003;20(10):808-11. DOI: 10.1046/j.1464-5491.2003.01029.x

8. Adamsson Eryd S, Svensson AM, Franzen S, Eliasson B, Nilsson PM, Gudbjornsdoffir S. Risk of future microvascular and macrovascular disease in people with Type 1 diabetes of very long duration: a national study with 10-year follow-up. Diabet Med. 2017;34(3):411-418. DOI: 10.1111/dme.13266

9. Tremmel M, Lyssenko V, Zoller B, Engstrom G, Magnusson M, Melander O, et al. Characteristics and prognosis of metabolically healthy obesity (MHO) - the Malmo Preventive Project. Obes Med. 2018;11:6-12. doi: 10.1016/j.obmed.2018.06.005.

10. Elagizi A, Kachur S, Lavie CJ, Carbone S, Pandey A, Ortega FB, et al. An Overview and Update on Obesity and the Obesity Paradox in Cardiovascular Diseases. Prog Cardiovasc Dis. 2018;61(2):142-150. DOI: 10.1016/j.pcad.2018.07.003

11. Nilsson PM. Hemodynamic Aging as the Consequence of Structural Changes Associated with Early Vascular Aging (EVA). Aging Dis. 2014;5(2):109-13. DOI: 10.14336/AD.2014.0500109

12. Mongraw-Chaffin M, Foster MC, Anderson CAM, Burke GL, Haq N, Kalyani RR, et al. Metabolically Healthy Obesity, Transition to Metabolic Syndrome, and Cardiovascular Risk. J Am Coll Cardiol. 2018;71(17):1857-1865. DOI: 10.1016/j.jacc.2018.02.055.

13. Шляхто Е.В., Недогода С.В., Конради А.О., Баранова Е.И., Фомин В.В., Верткин А.Л., и др. Концепция новых национальных клинических рекомендаций по ожирению. Российский кардиологический журнал. 2016;(4):7-13. DOI: 10.15829/1560-4071-2016-4-7-13

14. Stehouwer CD, Henry RM, Ferreira I. Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease. Diabetologia. 2008;51(4):527-39. DOI: 10.1007/s00125-007-0918-3

15. Topouchian J, Labat C, Gautier S, Back M, Achimastos A, Blacher J, et al. Effects of metabolic syndrome on arterial function in different age groups: the Advanced Approach to Arterial Stiffness study. J Hypertens. 2018;36(4):824-833. DOI: 10.1097/HJH.0000000000001631

16. Groenewegen KA, den Ruijter HM, Pasterkamp G, Polak JF, Bots ML, Peters SA. Vascular age to determine cardiovascular disease risk: A systematic review of its concepts, definitions, and clinical applications. Eur J Prev Cardiol. 2016;23(3):264-74. DOI: 10.1177/2047487314566999

17. Gurka MJ, Lilly CL, Oliver MN, DeBoer MD. An examination of sex and racial/ethnic differences in the metabolic syndrome among adults: a confirmatory factor analysis and a resulting continuous severity score. Metabolism. 2014;63(2):218-25. DOI: 10.1016/j.metabol.2013.10.006

18. Wiley JF, Carrington MJ. A metabolic syndrome severity score: A tool to quantify cardio-metabolic risk factors. Prev Med. 2016;88:189-95. DOI: 10.1016/j.ypmed.2016.04.006.

19. Gurka MJ, Golden SH, Musani SK, Sims M, Vishnu A, Guo Y, et al. Independent associations between a metabolic syndrome severity score and future diabetes by sex and race: the Atherosclerosis Risk In Communities Study and Jackson Heart Study. Diabetologia. 2017;60(7):1261-1270. DOI: 10.1007/s00125-017-4267-6

20. Taeber Rapczak. MetSCalc/metscalc: v0.1.0-alpha (Version 0.1.0-alpha). Zenodo. 2019, January 16. DOI: 10.5281/zeno-do.2542214

21. Nilsson PM, Laurent S, Cunha PG, Olsen MH, Rietzschel E, Franco OH, et al. Characteristics of healthy vascular ageing in pooled population-based cohort studies: the global Metabolic syndrome and Artery REsearch Consortium. J Hypertens. 2018;36(12):2340-2349. DOI: 10.1097/HJH.0000000000001824

22. Reference Values for Arterial Stiffness' Collaboration. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: 'establishing normal and reference values'. Eur Heart J. 2010;31(19):2338-50. DOI: 10.1093/eurheartj/ehq165

23. Greve SV, Blicher MK, Kruger R, Sehestedt T, Gram-Kampmann E, Rasmussen S, et al. Estimated carotid-femoral pulse wave velocity has similar predictive value as measured carotid-femoral pulse wave velocity. J Hypertens. 2016;34(7):1279-89. DOI: 10.1097/HJH.0000000000000935

24. Ротарь О.П., Алиева А.С., Бояринова М.А., Толкунова К.М., Конради А.О. Концепция сосудистого возраста: какой инструмент для оценки выбрать в клинической практике? Кардиология. 2019;59(2):45-53. DOI: 10.18087/cardio.2019.2.10229

25. Троицкая Е.А., Вельмакин С.В., Кобалава Ж.Д. Концепция сосудистого возраста: новый инструмент оценки сердечно-сосудистого риска. Артериальная гипертензия. 2017;23(2):160-171. DOI: 10.18705/1607-419X-2017-23-2-160-171

26. Betge S, Kretzschmar D, Figulla HR, Lichtenauer M, Jung C. Predictive value of the augmentation index derived vascular age in patients with newly diagnosed atherosclerosis. Heart Vessels. 2017;32(3):252-259. DOI: 10.1007/s00380-016-0868-0

27. McEniery CM, Yasmin, Hall IR, Qasem A, Wilkinson IB, Cockcroft JR; ACCT Investigators. Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: the Anglo-Cardiff Collaborative Trial (ACCT). J Am Coll Cardiol. 2005;46(9):1753-60. DOI: 10.1016/j.jacc.2005.07.037

28. Homma S, Hirose N, Ishida H, Ishii T, Araki G. Carotid plaque and intima-media thickness assessed by b-mode ultrasonography in subjects ranging from young adults to centenarians. Stroke. 2001;32(4):830-5. DOI: 10.1161/01.str.32.4.830

29. Аносова Е.В. Прощаев К.И. Применение в клинической практике показателя сосудистого возраста у больных аретриальной гипертензией на фоне гиперхолистеринемии в оценке эффективности липидснижающей терапии. Современные проблемы науки и образования. 2013;(1):44-44. eLIBRARY ID: 18828977

30. D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117(6):743-53. DOI: 10.1161/CIRCULA-TIONAHA.107.699579

31. Cuende JI, Cuende N, Calaveras-Lagartos J. How to calculate vascular age with the SCORE project scales: a new method of cardiovascular risk evaluation. Eur Heart J. 2010;31(19):2351-8. DOI: 10.1093/eurheartj/ehq205

32. Карпов Ю.А., Сорокин Е.В. Оценка риска осложнений при артериальной гипертонии и сосудистый возраст: новые инструменты для повышения качества лечения и улучшения взаимопонимания врача и больного. Атмосфера. Новости кардиологии. 2015;(2):18-25. eLIBRARY ID: 24930758

33. Карпов Ю.А., Сорокин Е.В. Влияние комбинированной гипотензивной терапии на риск сердечно-сосудистых осложнений и сосудистый возраст: результаты многоцентрового открытого исследования ADVANTAGE. Атмосфера. Новости кардиологии. 2015;(3):2-10. eLIBRARY ID: 25029045

34. Hippisley-Cox J, Coupland C, Brindle P. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study. BMJ. 2017;357:j2099. DOI: 10.1136/bmj.j2099

35. Grundy SM. Pre-diabetes, metabolic syndrome, and cardiovascular risk. J Am Coll Cardiol. 2012;59(7):635-43. DOI: 10.1016/j.jacc.2011.08.080

36. Terentes-Printzios D, Vlachopoulos C, Xaplanteris P, Ioakeimidis N, Aznaouridis K, Baou K, et al. Cardiovascular Risk Factors Accelerate Progression of Vascular Aging in the General Population: Results From the CRAVE Study (Cardiovascular Risk Factors Affecting Vascular Age). Hypertension. 2017;70(5):1057-1064. DOI: 10.1161/HYPERTENSIO-NAHA.117.09633

37. Vlachopoulos C, Xaplanteris P, Aboyans V, Brodmann M, Cfkova R, Cosentino F, et al. The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation: Endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) Society. Atherosclerosis. 2015;241(2):507-32. DOI: 10.1016/j.atherosclerosis.2015.05.007

38. Васюк Ю.А., Иванова С.В., Школьник Е.Л., Котовская Ю.В., Милягин В.А., Олейников В.Э., и др. Согласованное мнение российских экспертов по оценке артериальной жесткости в клинической практике. Кардиоваскулярная терапия и профилактика. 2016;15(2):4-19. DOI: 10.15829/1728-8800-2016-2-4-19

39. Townsend RR, Wilkinson IB, Schiffrin EL, Avolio AP, Chirinos JA, Cockcroft JR, et al. Recommendations for Improving and Standardizing Vascular Research on Arterial Stiffness: A Scientific Statement From the American Heart Association. Hypertension. 2015;66(3):698-722. DOI: 10.1161/HYP.0000000000000033